| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
L1 cell adhesion molecule | 0.475 | 0.769 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
kynurenine 3-monooxygenase | 0.674 | 0.615 | 4.8E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.510 | None | 1.000 | 1 | 0 | 2011 | 2018 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.600 | None | 0.800 | 2 | 0 | 1995 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.600 | None | 0.800 | 1 | 0 | 1999 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1998 | 2020 | ||||||||
|
histone deacetylase 5 | 0.552 | 0.769 | 1.00 |
|
disease | 0.500 | None | 0.500 | 1 | 0 | 2006 | 2014 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.580 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
Fas associated via death domain | 0.537 | 0.846 | 0.53 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2011 | 2017 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
dopamine receptor D1 | 0.529 | 0.808 | 0.96 |
|
disease | 0.530 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.530 | None | 1.000 | 1 | 0 | 1993 | 2013 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2010 | ||||||||
|
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene) | 0.659 | 0.577 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2010 | 2018 | |||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
disease | 0.520 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
corticotropin releasing hormone binding protein | 0.659 | 0.500 | 0.21 |
|
disease | 0.520 | None | 1.000 | 1 | 0 | 1996 | 2010 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1992 | 2019 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2002 | 2011 | ||||||||
|
cyclin dependent kinase 5 | 0.495 | 0.846 | 0.14 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.600 | None | 1.000 | 3 | 0 | 2003 | 2020 |